Description
ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC
Modification chain · 18 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-10-01+$56,497= $56,497
- Mod P000012021-06-01+$348,029= $404,527
- Mod P000022021-09-20+$0= $404,527
- Mod P000032021-10-01+$56,497= $461,024
- Mod P000042021-12-22-$35,833= $425,192
- Mod P000052022-01-14-$178,804= $246,387
- Mod P000062022-09-29+$0= $246,387
- Mod P000072022-10-01+$56,497= $302,885
- Mod P000082023-01-06-$32,320= $270,565
- Mod P000092023-04-20+$21,584= $292,149
- Mod P000102023-09-23+$0= $292,149
- Mod P000112023-10-01+$87,583= $379,732
- Mod P000122023-12-29-$27,055= $352,677
- Mod P000132024-09-26+$0= $352,677
- Mod P000142024-10-01+$17,270= $369,947
- Mod P000152024-11-19-$42,785= $327,162
- Mod P000162025-01-16-$14,235= $312,928
- Mod P000172025-11-07-$17,270= $295,658
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-10-01 | +$56,497 | $56,497 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00001· FUNDING ONLY ACTION | 2021-06-01 | +$348,029 | $404,527 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00002· EXERCISE AN OPTION | 2021-09-20 | +$0 | $404,527 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00003· EXERCISE AN OPTION | 2021-10-01 | +$56,497 | $461,024 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-22 | −$35,833 | $425,192 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00005· FUNDING ONLY ACTION | 2022-01-14 | −$178,804 | $246,387 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00006· EXERCISE AN OPTION | 2022-09-29 | +$0 | $246,387 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00007· EXERCISE AN OPTION | 2022-10-01 | +$56,497 | $302,885 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-01-06 | −$32,320 | $270,565 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-04-20 | +$21,584 | $292,149 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00010· EXERCISE AN OPTION | 2023-09-23 | +$0 | $292,149 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00011· EXERCISE AN OPTION | 2023-10-01 | +$87,583 | $379,732 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-12-29 | −$27,055 | $352,677 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00013· EXERCISE AN OPTION | 2024-09-26 | +$0 | $352,677 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00014· FUNDING ONLY ACTION | 2024-10-01 | +$17,270 | $369,947 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00015· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-11-19 | −$42,785 | $327,162 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00016· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-01-16 | −$14,235 | $312,928 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
| Mod P00017· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-11-07 | −$17,270 | $295,658 | ONCOTYPE DX GENOMIC TESTING SUITE FOR RICHMOND VAMC |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NGBXEJX5GLE9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25726N0419 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $127,174 | FY2026 |
| 36C25726N0252 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · Q301 · REFERENCE LABORATORY TESTING | $52,215 | FY2026 |
| 36C25526N0057 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0054 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $24,259 | FY2026 |
| 36C25526N0056 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,454 | FY2026 |
| 36C25526N0055 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q301 · REFERENCE LABORATORY TESTING | $3,116 | FY2026 |
Other recipients under Q301 from 246-NETWORK CONTRACTING OFFICE 6 (36C246) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24626P0867 | NATERA INC | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $48,000 | FY2026 |
| 36C24626P0726 | ARTERA INC. | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $79,782 | FY2026 |
| 36C24626P0332 | VIRGINIA COMMONWEALTH UNIVERSITY HEALTH SYSTEM AUTHORITY | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $61,859 | FY2026 |
| 36C24626N0656 | QUEST DIAGNOSTICS INCORPORATED | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $640,000 | FY2026 |
| 36C24626N0657 | QUEST DIAGNOSTICS INCORPORATED | 246-NETWORK CONTRACTING OFFICE 6 (36C246) | $1,599,984 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24621F0006_3600_V797D70053_3600 · retrieved 2026-09-26.